STOK – stoke therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Stoke Therapeutics CMO Sells $457,000 in Stock Amid 300% Rally [Yahoo! Finance]
Stoke Therapeutics (STOK) had its price target raised by Canaccord Genuity Group Inc. from $36.00 to $60.00. They now have a "buy" rating on the stock.
Stoke Therapeutics (STOK) had its "buy" rating reaffirmed by BTIG Research. They now have a $39.00 price target on the stock.
Stoke Therapeutics (STOK) had its "buy" rating reaffirmed by Chardan Capital. They now have a $35.00 price target on the stock.
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Form 8-K Stoke Therapeutics, Inc. For: Mar 23
Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Form 4 Stoke Therapeutics, Inc. For: Mar 20 Filed by: Allan Jonathan
Form 144 Stoke Therapeutics, Inc. Filed by: Allan Jonathan
Form 4 Stoke Therapeutics, Inc. For: Mar 17 Filed by: Ticho Barry
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.